InflaRx (NASDAQ:IFRX) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.22) by 15.91 percent. The company reported quarterly sales of $39.138 thousand which missed the analyst consensus estimate of $1.268 million by 96.91 percent.
InflaRx Q1 2024 GAAP EPS $(0.18) Beats $(0.22) Estimate, Sales $39.138K Miss $1.268M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.